Cover Image

Panhypopituitarism induced by ipilimumab

Saved in:

Bibliographic Details
Main Authors:	Miyu Shiratori (Author), Toshiyuki Ozawa (Author), Daichi Miyaoka (Author), Yasuo Imanishi (Author), Daisuke Tsuruta (Author)
Format:	Book
Published:	Wolters Kluwer Medknow Publications, 2020-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Panhypopituitarism Secondary to Pituitary Macroadenoma
by: Samuel Sánchez Sánchez, et al.
Published: (2021)

Congenital panhypopituitarism unmasked by PHACE screening
by: Paula Finnegan, MB BaO, BCH, BA, MRCPI, et al.
Published: (2023)

Postpartum psychosis as a presentation of panhypopituitarism
by: Jananee Muralidharan, et al.
Published: (2024)

Ipilimumab-Induced Neutropenia in Melanoma
by: Makiko Ban-Hoefen MD, et al.
Published: (2016)

Panhypopituitarism in adults: modern views and case analysis
by: L. M. Farkhutdinova
Published: (2019)

Management of panhypopituitarism during pregnancy: A case report
by: Sofie Karolina Maria van Zundert, et al.
Published: (2021)

A case of 18p deletion syndrome with panhypopituitarism
by: Aram Yang, et al.
Published: (2019)

Life-Threatening Hypernatremia In A Case Of Diabetes Insipidus/Panhypopituitarism
by: Ekamol Tantisattamo, et al.
Published: (2012)

comment: Clinical evaluation of different therapeutic modalities in psoriasis by Pasi score
by: Hisayoshi Imanishi, et al.
Published: (2013)

Ipilimumab: Melanoma and beyond
by: Vishal Patel, et al.
Published: (2011)

Newborn with Prenatally Diagnosed Choroidal Fissure Cyst and Panhypopituitarism and Review of the Literature
by: Ritu Chitkara, et al.
Published: (2011)

A case of dupilumab‐induced psoriasis‐like eruption treated with baricitinib
by: Yuki Kinoshita, et al.
Published: (2024)

A case of ruptured Baker's cyst induced by nivolumab and ipilimumab
by: Marie Kubo, et al.
Published: (2023)

Use of ipilimumab in the treatment of melanoma
by: Acharya UH, et al.
Published: (2013)

Association of Slipped Capital Femoral Epiphysis With Panhypopituitarism Due to Pituitary Macroadenoma: A Case Report
by: James B. Harris, et al.
Published: (2021)

A case of a long-neglected basal cell carcinoma on the scalp
by: Hiroki Furukawa, et al.
Published: (2021)

Urticaria multiforme following nivolumab-ipilimumab therapy
by: Sonal Muzumdar, et al.
Published: (2020)

Ipilimumab and nivolumab for recurrent neuroendocrine cervical carcinoma
by: Mary Towner, et al.
Published: (2022)

Photosensitive Dermatitis Induced by Nivolumab/Ipilimumab Combination Therapy in a Patient with Malignant Melanoma
by: Yuri Sakaguchi, et al.
Published: (2020)

Ipilimumab and Nivolumab induced ventricular tachycardia in a patient with metastatic renal cell carcinoma
by: Pramod Savarapu, et al.
Published: (2021)

Comparisons of therapeutic efficacy and safety of ipilimumab plus GM-CSF versus ipilimumab alone in patients with cancer: a meta-analysis of outcomes
by: Chen P, et al.
Published: (2018)

Ustekinumab successfully treated a patient with severe psoriasis vulgaris with primary failure to infliximab and secondary failure to adalimumab
by: Chiharu Tateishi, et al.
Published: (2015)

CD30+ lymphomatoid skin toxicity secondary to ipilimumab
by: Amelia E. Bush, BS, et al.
Published: (2020)

Profile of ipilimumab and its role in the treatment of metastatic melanoma
by: Patel SP, et al.
Published: (2011)

Checkpoint inhibitor immunotherapy induced inflammatory arthritis secondary to Nivolumab and Ipilimumab: a pediatric first
by: John A. Storwick, et al.
Published: (2024)

Body composition is prognostic and predictive of ipilimumab activity in metastatic melanoma
by: Michael P. Chu, et al.
Published: (2020)

Population Pharmacokinetics of Nivolumab in Combination With Ipilimumab in Patients With Advanced Malignancies
by: Jason Zhang, et al.
Published: (2019)

Two Cases of Unilateral Ashy Dermatosis
by: Hisayoshi Imanishi, et al.
Published: (2011)

Population Pharmacokinetics of Ipilimumab in Combination With Nivolumab in Patients With Advanced Solid Tumors
by: Kinjal Sanghavi, et al.
Published: (2020)

Ipilimumab, a Promising Immunotherapy with Increased Overall Survival in Metastatic Melanoma?
by: Gérald E. Piérard, et al.
Published: (2012)

HLA Class I Downregulation in Progressing Metastases of Melanoma Patients Treated With Ipilimumab
by: Andrea Ladányi, et al.
Published: (2022)

Characterization of the human gut virome in metabolic and autoimmune diseases
by: Kosuke Fujimoto, et al.
Published: (2022)

Sequential therapy with INCAGN01949 followed by ipilimumab and nivolumab in two patients with advanced ovarian carcinoma
by: Andrey Moiseyenko, et al.
Published: (2020)

Cost-Effectiveness Analysis of Nivolumab Plus Ipilimumab for Advanced Non-Small-Cell Lung Cancer
by: Xiaomin Wan, et al.
Published: (2021)

Nivolumab and Ipilimumab Acting as Tormentors of Advanced Tumors by Unleashing Immune Cells and Associated Collateral Damage
by: Bushra Khan, et al.
Published: (2024)

A real world example of coverage with evidence development in Australia - ipilimumab for the treatment of metastatic melanoma
by: Hansoo Kim, et al.
Published: (2018)

Hyponatremia and Fever in a Patient on Ipilimumab and Nivolumab (Immune Checkpoint Inhibitors): A Case Report
by: Sumit S. Patel MD, et al.
Published: (2021)

comment:A study on the clinical and hormonal profile of patients with hirsutism
by: Daisuke Tsuruta
Published: (2012)

Complications in Infants of Diabetic Mothers Related to Glycated Albumin and Hemoglobin Levels During Pregnancy
by: Daisuke Sugawara, et al.
Published: (2016)

Lichen striatus as an immune-related adverse event following ipilimumab/nivolumab and COVID-19 infection in an adult
by: Courtney M. Kenyon, BS, et al.
Published: (2024)